VRCA - Verrica Pharma gains as FDA lists Ycanth in Orange Book
2024-03-26 13:33:07 ET
More on Verrica Pharmaceuticals
- Verrica Pharmaceuticals Inc. (VRCA) Q4 2023 Earnings Call Transcript
- Verrica sues to keep unapproved cantharidin drugs off US market
- Verrica Pharmaceuticals stock gains on Walgreens distribution deal
- Seeking Alpha’s Quant Rating on Verrica Pharmaceuticals
- Historical earnings data for Verrica Pharmaceuticals